Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT
医学
协商一致会议
重症监护医学
肺
内科学
作者
Geert M. Verleden,Allan R. Glanville,Erika D. Lease,Andrew J. Fisher,Fiorella Calabrese,Paul A. Corris,Christopher R. Ensor,Jens Gottlieb,Ramsey R. Hachem,Vibha N. Lama,Tereza Martinu,Desley Neil,L.G. Singer,Greg Snell,Robin Vos
The outcomes of transplantation vary widely by organ. Lung transplantation (LTx) has rather poor long-term outcome, with a current median post-transplant survival of 6.0 years.1,2 Survival after organ transplantation is limited by both graft-related and non‒graft-related factors. Allograft failure remains the leading cause of morbidity and mortality across all organ groups and is the major cause of death, accounting for >40% of deaths beyond the first year post-LTx.1,2